These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradication. Poonam ; Gupta Y; Gupta N; Singh S; Wu L; Chhikara BS; Rawat M; Rathi B Med Res Rev; 2018 Sep; 38(5):1511-1535. PubMed ID: 29372568 [TBL] [Abstract][Full Text] [Related]
3. Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages. Smith PW; Diagana TT; Yeung BK Parasitology; 2014 Jan; 141(1):66-76. PubMed ID: 23746048 [TBL] [Abstract][Full Text] [Related]
4. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box. Bowman JD; Merino EF; Brooks CF; Striepen B; Carlier PR; Cassera MB Antimicrob Agents Chemother; 2014; 58(2):811-9. PubMed ID: 24247137 [TBL] [Abstract][Full Text] [Related]
5. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials. Abraham M; Gagaring K; Martino ML; Vanaerschot M; Plouffe DM; Calla J; Godinez-Macias KP; Du AY; Wree M; Antonova-Koch Y; Eribez K; Luth MR; Ottilie S; Fidock DA; McNamara CW; Winzeler EA ACS Infect Dis; 2020 Apr; 6(4):613-628. PubMed ID: 32078764 [TBL] [Abstract][Full Text] [Related]
6. Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways. Allman EL; Painter HJ; Samra J; Carrasquilla M; Llinás M Antimicrob Agents Chemother; 2016 Nov; 60(11):6635-6649. PubMed ID: 27572391 [TBL] [Abstract][Full Text] [Related]
7. An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins. Madhav H; Hoda N Eur J Med Chem; 2021 Jan; 210():112955. PubMed ID: 33131885 [TBL] [Abstract][Full Text] [Related]
8. Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc. Calit J; Araújo JE; Deng B; Miura K; Gaitán XA; Araújo MDS; Medeiros JF; Long CA; Simeonov A; Eastman RT; Bargieri DY Antimicrob Agents Chemother; 2023 Apr; 67(4):e0146522. PubMed ID: 36856421 [TBL] [Abstract][Full Text] [Related]
9. The antimalarial resistome - finding new drug targets and their modes of action. Carolino K; Winzeler EA Curr Opin Microbiol; 2020 Oct; 57():49-55. PubMed ID: 32682267 [TBL] [Abstract][Full Text] [Related]
10. The Development Process for Discovery and Clinical Advancement of Modern Antimalarials. Ashton TD; Devine SM; Möhrle JJ; Laleu B; Burrows JN; Charman SA; Creek DJ; Sleebs BE J Med Chem; 2019 Dec; 62(23):10526-10562. PubMed ID: 31385706 [TBL] [Abstract][Full Text] [Related]
12. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery. Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic Screens in Antimalarial Drug Discovery. Hovlid ML; Winzeler EA Trends Parasitol; 2016 Sep; 32(9):697-707. PubMed ID: 27247245 [TBL] [Abstract][Full Text] [Related]
14. [In vitro cultivation of Plasmodium falciparum. Applications and limits.- Methodology]. Druilhe P; Gentilini M Med Trop (Mars); 1982; 42(4):437-62. PubMed ID: 6755144 [TBL] [Abstract][Full Text] [Related]
15. Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of action. Luo AP; Giannangelo C; Siddiqui G; Creek DJ Front Cell Infect Microbiol; 2023; 13():1308193. PubMed ID: 38162576 [TBL] [Abstract][Full Text] [Related]
16. Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38. Armstrong JF; Campo B; Alexander SPH; Arendse LB; Cheng X; Davenport AP; Faccenda E; Fidock DA; Godinez-Macias KP; Harding SD; Kato N; Lee MCS; Luth MR; Mazitschek R; Mittal N; Niles JC; Okombo J; Ottilie S; Pasaje CFA; Probst AS; Rawat M; Rocamora F; Sakata-Kato T; Southan C; Spedding M; Tye MA; Yang T; Zhao N; Davies JA Br J Pharmacol; 2023 Aug; 180(15):1899-1929. PubMed ID: 37197802 [TBL] [Abstract][Full Text] [Related]
17. Discovery of Dual-Stage Malaria Inhibitors with New Targets. Raphemot R; Lafuente-Monasterio MJ; Gamo-Benito FJ; Clardy J; Derbyshire ER Antimicrob Agents Chemother; 2015 Dec; 60(3):1430-7. PubMed ID: 26666931 [TBL] [Abstract][Full Text] [Related]
18. A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes. Vos MW; Stone WJ; Koolen KM; van Gemert GJ; van Schaijk B; Leroy D; Sauerwein RW; Bousema T; Dechering KJ Sci Rep; 2015 Dec; 5():18704. PubMed ID: 26687564 [TBL] [Abstract][Full Text] [Related]
19. Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs. Delves MJ Future Med Chem; 2012 Dec; 4(18):2251-63. PubMed ID: 23234549 [TBL] [Abstract][Full Text] [Related]
20. Screening the Pathogen Box for Molecules Active against Plasmodium Sexual Stages Using a New Nanoluciferase-Based Transgenic Line of P. berghei Identifies Transmission-Blocking Compounds. Calit J; Dobrescu I; Gaitán XA; Borges MH; Ramos MS; Eastman RT; Bargieri DY Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]